The Role of Interferon-γ Inducible Protein-10 in a Mouse Model of Acute Liver Injury Post Induced Pluripotent Stem Cells Transplantation

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Chan, Che Chang ^a,c   Cheng, Ling Yi ^a,c   Lu, Jean ^b   Huang, Yi Hsiang ^a,c   Chiou, Shih Hwa ^a,c   Tsai, Ping Hsing ^a,c   Huo, Teh Ia ^a,c   Lin, Han Chieh ^c   Lee, Fa Yauh ^c  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b GENOMICS RESEARCH CENTER   (Taiwan)

^c TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; MESSENGER RNA; NEUTRALIZING ANTIBODY; RECOMBINANT GAMMA INTERFERON INDUCIBLE PROTEIN 10; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOKINE RESPONSE; GENE; GENE EXPRESSION REGULATION; IMMUNOREGULATION; IN VITRO STUDY; IP 10 GENE; LIVER INJURY; LIVER NECROSIS; LIVER PROTECTION; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; STEM CELL TRANSPLANTATION;

ANIMALS; BLOTTING, WESTERN; CHEMOKINE CXCL10; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; LIVER; MICE; MICE, INBRED C57BL; PLURIPOTENT STEM CELLS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STEM CELL TRANSPLANTATION;

ANIMALIA; IPS; MUS;

EID: 84870813033     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050577     Document Type: Article

References (37)

1. Fox IJ, Roy-Chowdhury J, (2004) Hepatocyte transplantation. Journal of hepatology 40: 878-886.
2. Kawashita Y, Guha C, Yamanouchi K, Ito Y, Kamohara Y, et al. (2005) Liver repopulation: a new concept of hepatocyte transplantation. Surg Today 35: 705-710.
3. Puppi J, Dhawan A, (2009) Human hepatocyte transplantation overview. Methods Mol Biol 481: 1-16.
4. Kakinuma S, Nakauchi H, Watanabe M, (2009) Hepatic stem/progenitor cells and stem-cell transplantation for the treatment of liver disease. J Gastroenterol 44: 167-172.
5. Navarro-Alvarez N, Soto-Gutierrez A, Kobayashi N, (2009) Stem cell research and therapy for liver disease. Curr Stem Cell Res Ther 4: 141-146.
6. Yoshimi A, Nannya Y, Ueda K, Asano D, Yamamoto G, et al. (2009) Successful hematopoietic stem cell transplantation from an HLA-identical sibling in a patient with aplastic anemia after HLA-haploidentical living-related liver transplantation for fulminant hepatitis. Biol Blood Marrow Transplant 15: 389-390.
7. Si-Tayeb K, Noto FK, Nagaoka M, Li J, Battle MA, et al. (2010) Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology (Baltimore, Md) 51: 297-305.
8. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
9. Okita K, Ichisaka T, Yamanaka S, (2007) Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-317.
10. Xu D, Alipio Z, Fink LM, Adcock DM, Yang J, et al. (2009) Phenotypic correction of murine hemophilia A using an iPS cell-based therapy. Proc Natl Acad Sci U S A 106: 808-813.
11. Espejel S, Roll GR, McLaughlin KJ, Lee AY, Zhang JY, et al. (2010) Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice. The Journal of clinical investigation 120: 3120-3126.
12. Song Z, Cai J, Liu Y, Zhao D, Yong J, et al. (2009) Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell research 19: 1233-1242.
13. Flohr TR, Bonatti H Jr, Brayman KL, Pruett TL, (2009) The use of stem cells in liver disease. Curr Opin Organ Transplant 14: 64-71.
14. Parekkadan B, van Poll D, Suganuma K, Carter EA, Berthiaume F, et al. (2007) Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS One 2: e941.
15. Taniguchi E, Kin M, Torimura T, Nakamura T, Kumemura H, et al. (2006) Endothelial progenitor cell transplantation improves the survival following liver injury in mice. Gastroenterology 130: 521-531.
16. Yamanouchi K, Zhou H, Roy-Chowdhury N, Macaluso F, Liu L, et al. (2009) Hepatic irradiation augments engraftment of donor cells following hepatocyte transplantation. Hepatology (Baltimore, Md) 49: 258-267.
17. Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YR, et al. (2008) Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 134: 2111-2121, 2121 e2111-2113.
18. Nanji AA, Jokelainen K, Rahemtulla A, Miao L, Fogt F, et al. (1999) Activation of nuclear factor kappa B and cytokine imbalance in experimental alcoholic liver disease in the rat. Hepatology (Baltimore, Md) 30: 934-943.
19. Narumi S, Tominaga Y, Tamaru M, Shimai S, Okumura H, et al. (1997) Expression of IFN-inducible protein-10 in chronic hepatitis. J Immunol 158: 5536-5544.
20. Zeremski M, Petrovic LM, Chiriboga L, Brown QB, Yee HT, et al. (2008) Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology (Baltimore, Md). 48: 1440-1450.
21. Bone-Larson CL, Hogaboam CM, Evanhoff H, Strieter RM, Kunkel SL, (2001) IFN-gamma-inducible protein-10 (CXCL10) is hepatoprotective during acute liver injury through the induction of CXCR2 on hepatocytes. J Immunol 167: 7077-7083.
22. Njoku DB, Li Z, Mellerson JL, Sharma R, Talor MV, et al. (2009) IP-10 protects while MIP-2 promotes experimental anesthetic hapten- induced hepatitis. J Autoimmun 32: 52-59.
23. Yoneyama H, Kai Y, Koyama J, Suzuki K, Kawachi H, et al. (2007) Neutralization of CXCL10 accelerates liver regeneration in carbon tetrachloride-induced acute liver injury. Med Mol Morphol 40: 191-197.
24. Zhai Y, Shen XD, Gao F, Zhao A, Freitas MC, et al. (2008) CXCL10 regulates liver innate immune response against ischemia and reperfusion injury. Hepatology (Baltimore, Md) 47: 207-214.
25. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, et al. (2009) Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J Gastroenterol Hepatol 24: 70-77.
26. Farber JM, (1997) Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 61: 246-257.
27. Heydtmann M, Adams DH, (2009) Chemokines in the immunopathogenesis of hepatitis C infection. Hepatology (Baltimore, Md) 49: 676-688.
28. Mach F, Sauty A, Iarossi AS, Sukhova GK, Neote K, et al. (1999) Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. The Journal of clinical investigation 104: 1041-1050.
29. Wasmuth HE, Lammert F, Zaldivar MM, Weiskirchen R, Hellerbrand C, et al. (2009) Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans. Gastroenterology 137: 309-319, 319 e301-303.
30. Koniaris LG, Zimmers-Koniaris T, Hsiao EC, Chavin K, Sitzmann JV, et al. (2001) Cytokine-responsive gene-2/IFN-inducible protein-10 expression in multiple models of liver and bile duct injury suggests a role in tissue regeneration. J Immunol 167: 399-406.
31. Tager AM, Kradin RL, LaCamera P, Bercury SD, Campanella GS, et al. (2004) Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10. American journal of respiratory cell and molecular biology 31: 395-404.
32. Jiang D, Liang J, Campanella GS, Guo R, Yu S, et al. (2010) Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4. The Journal of clinical investigation 120: 2049-2057.
33. Singh UP, Singh S, Singh R, Cong Y, Taub DD, et al. (2008) CXCL10-producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-/-) mice, which can be abrogated by anti-CXCL10 antibody inhibition. Journal of interferon & cytokine research: the official journal of the International Society for Interferon and Cytokine Research 28: 31-43.
34. Nakaya I, Wada T, Furuichi K, Sakai N, Kitagawa K, et al. (2007) Blockade of IP-10/CXCR3 promotes progressive renal fibrosis. Nephron Experimental nephrology 107: e12-21.
35. Yoneyama H, Kai Y, Koyama J, Suzuki K, Kawachi H, et al. (2007) Neutralization of CXCL10 accelerates liver regeneration in carbon tetrachloride-induced acute liver injury. Medical molecular morphology 40: 191-197.
36. Heydtmann M, Adams DH, (2009) Chemokines in the immunopathogenesis of hepatitis C infection. Hepatology 49: 676-688.
37. Kao CL, Tai LK, Chiou SH, Chen YJ, Lee KH, et al. (2010) Resveratrol promotes osteogenic differentiation and protects against dexamethasone damage in murine induced pluripotent stem cells. Stem Cells Dev 19: 247-258.